Cite
MLA Citation
Ayako Yamaguchi et al.. “5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study.” Modern rheumatology, vol. 30, no. 5, 2020, pp. 799–806. http://access.bl.uk/ark:/81055/vdc_100106907306.0x000023